Previously, Dr Wotton served as CEO of Topigen Pharmaceuticals. Prior to joining Topigen, Dr Wotton served as head of global business development at SkyePharma.
Dr Wotton has over 20 years experience in the pharmaceutical industry with both large and specialty pharma companies. He received his PhD in pharmaceutical science from the University of Nottingham.
Jack Stover, CEO of Antares Pharma, said: “We are pleased to have Dr Wotton, a seasoned executive, join Antares; he brings a wealth of business and product development experience to our executive management team.”